PRF1 and cancer: Mechanistically, CD8+TRM cells release TNF-α, IFN-γ, perforin, and GZMB to perform cancer-inhibiting functions.239,613–615 Interestingly, these tissue-resident molecules such as CD103 extensively expressed by TRICs also regulate cancer immunity, not limited to the residency-related effects.